首页 | 本学科首页   官方微博 | 高级检索  
     

参芪降糖颗粒合吡格列酮二甲双胍对糖尿病合并代谢综合征的影响
引用本文:郑谌,朱俊,何先凤,鲁佳,沈馨茹. 参芪降糖颗粒合吡格列酮二甲双胍对糖尿病合并代谢综合征的影响[J]. 世界中医药, 2022, 17(2): 237-242. DOI: 10.3969/j.issn.1673-7202.2022.02.017
作者姓名:郑谌  朱俊  何先凤  鲁佳  沈馨茹
作者单位:德驭医疗马鞍山总医院内分泌,马鞍山,243000;马鞍山市十七冶医院内分泌科,马鞍山,243000;马鞍山市人民医院内分泌科,马鞍山,243000
基金项目:国家青年科学基金项目(WJ2021Q069)。
摘    要:目的:探讨吡格列酮二甲双胍联合参芪降糖颗粒治疗2型糖尿病合并代谢综合征患者的临床效果.方法:选取2020年3月至2021年7月德驭医疗马鞍山总医院收治的2型糖尿病合并代谢综合征患者60例作为研究对象,采用随机数字表法分为对照组和观察组,每组30例.对照组采取吡格列酮二甲双胍进行治疗,观察组在对照组治疗基础上增加参芪降糖...

关 键 词:2型糖尿病  代谢综合征  吡格列酮二甲双胍  参芪降糖颗粒  炎症介质  胰岛素抵抗  血糖  不良反应  临床疗效

Effects of Shenqi Jiangtang Granules Combined with Pioglitazone Metformin on Diabetes Mellitus Complicated with Metabolic Syndrome
ZHENG Chen,ZHU Jun,HE Xianfeng,LU Jia,SHEN Xinru. Effects of Shenqi Jiangtang Granules Combined with Pioglitazone Metformin on Diabetes Mellitus Complicated with Metabolic Syndrome[J]. World Chinese Medicine, 2022, 17(2): 237-242. DOI: 10.3969/j.issn.1673-7202.2022.02.017
Authors:ZHENG Chen  ZHU Jun  HE Xianfeng  LU Jia  SHEN Xinru
Affiliation:(Department of Endocrinology,Deyu Medical Maanshan General Hospital,Maanshan 243000,China;Department of Endocrinology,17th Metallurgical Hospital,Ma ′anshan,243000,China;Department of Endocrinology,Maanshan People′s Hospital,Maanshan 243000,China)
Abstract:Objective:To explore the effect of pioglitazone metformin combined with Shenqi Jiangtang Granules on type 2 diabetes mellitus patients with metabolic syndrome.Methods:A total of 60 patients with type 2 diabetes mellitus complicated with metabolic syndrome admitted to Deyu Medical Maanshan General Hospital from March 2020 to July were selected as the subjects and were divided into a control group(n=30)and an observation group(n=30)by random number.The control group was treated with pioglitazone metformin,and the observation group was additionally treated with Shenqi Jiangtang Granules on the basis of the control group.Glycated hemoglobin(HbA1c),inflammatory mediator transforming growth factor-β1(TGF-β1),serum high-sensitivity C-reactive protein(hs-CRP),vascular cell adhesion molecule-1(VCAM-1),human granulin precursor(PGRN),cysteine-rich acidic secretory protein(SPARC),islet cell function insulin resistance index(HOMA-IR),insulin secretion index(HOMA-β),fasting insulin(FINS),blood pressure,blood lipids,body mass and the incidence of adverse reactions and other indicators.Results:The total effective rate of the observation group was higher than the control group significantly(P<0.05);The blood glucose levels of FBG,2hPBGand HbA1c in the observation group were lower than those in the control group significantly(P<0.05);Compared with the control group,PGRN and TGF in the observation group-β1.The levels of inflammatory factors such as SPARC,VCAM-1 and hs CRP were significantly lower(P<0.05);Fins,HOMA-IR and HOMA in control group and observation group-βThere was significant difference in the function of islet cells(P<0.05);The incidence of adverse reactions in the observation group was lower than that in the control group significantly(P<0.05);The WC,BMI,SBP,DBP and other indicators of the observation group were significantly lower than those of the control group(P<0.05);the observation group′s LDL-C,TG,TC and other parameters were significantly lower than the control group(P<0.05).Conclusion:Pioglitazone metformin combined with Shenqi Jiangtang Granules for treatment of patients with type 2 diabetes mellitus and metabolic syndrome can achieve ideal results,which can better improve the blood sugar level of patients,reduce the level of inflammatory mediators,and improve islet cell function,with high safety.It has great promotion value.
Keywords:Type 2 diabetes mellitus  Metabolic syndrome  Pioglitazone Metformin  Shenqi Jiangtang granule  Inflammatory factors  Insulin resistance  Blood glucose  Adverse reactions  Effect
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号